论文部分内容阅读
从数据库容量、资源组织模式、检索功能,用户群体四个角度、15个子因素,对比分析MEDLINE、BP、MIS、VMIS、CBM5个国内外著名生物医药类数据库产品,总结国内数据库存在着容量小、架构不合理、低水平重复建设、市场占有率低的问题;进而分析产生差距的产业层面的原因主要是产业规模小、发展环境差、缺乏统一管理、产业影响力度低;针对这些问题,建议我国数据库服务业实施强强联合、政府引导、制定规划、打造品牌的发展策略。
From the four perspectives of database capacity, resource organization mode, retrieval function and user group, 15 sub-factors were compared and analyzed. Five famous biomedical database products of MEDLINE, BP, MIS, VMIS and CBM were compared and analyzed. Unreasonable structure, low-level redundant construction, and low market share. The reasons for the industrial-level differences in the analysis are mainly the small-scale industries, the poor development environment, the lack of unified management and the low industrial influence. In view of these problems, it is suggested that China The implementation of strong combination of database services industry, government guidance, development planning, build brand development strategy.